Chordoma: all 68 studies
Page 1 of 1. Open to participants first (15), then studies with results posted, then the rest; newest registration first within each.
- Clinical Genetics Branch Eligibility Screening SurveyNot yet recruitingNCT07005297
- Pembrolizumab and Pemetrexed for Progressive ChordomaRecruitingNCT06794645Phase 2
- Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid TumorsRecruitingNCT06625190Phase 1/2
- Exploration of Personalized Biomarkers During Neoadjuvant Radiation Therapy for Spinal and Sacral ChordomaRecruitingNCT06463262
- Apatinib Combined With Camrelizumab in Treating Participants With Advanced ChordomaRecruitingNCT06140732Phase 2
- Analysis of the Toxicity and Efficacy of Daily 1 vs 2 Beam Proton TherapyRecruitingNCT06029218Not applicable
- Multi-parametric Imaging in Personalized RadiotherapyRecruitingNCT05888064
- Hypofractionated Protontherapy in Chordomas and Chondrosarcomas of the Skull BaseRecruitingNCT05861245Not applicable
- Study to Evaluate the Efficacy of Afatinib in Skull Base ChordomaNot yet recruitingNCT05519917Phase 2
- Comparing Carbon Ion Therapy, Surgery, and Proton Therapy for Management of Pelvic Sarcomas Involving the BoneRecruitingNCT05033288
- Image Assisted Optimization of Proton Radiation Therapy in Chordomas and ChondrosarcomasRecruitingNCT04832620
- BLESSED: Expanded Access for DNG64-CAR-V for Advanced Pancreatic Cancer, Sarcoma and Carcinoma of BreastAvailableNCT04091295
- Children and Adults With ChordomaRecruitingNCT03910465
- Trial of Palbociclib in Second Line of Advanced Sarcomas With CDK4 Overexpression.RecruitingNCT03242382Phase 2
- Sacral Chordoma: Surgery Versus Definitive Radiation Therapy in Primary Localized DiseaseRecruitingNCT02986516Not applicable
- Study of Nivolumab and Ipilimumab in Children and Young Adults With INI1-Negative CancersActive, not recruitingNCT04416568Phase 2Results posted
- BN Brachyury and Radiation in ChordomaCompletedNCT03595228Phase 2Results posted
- Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain CancersCompletedNCT03190174Phase 1/2Results posted
- QUILT-3.011 Phase 2 Yeast-Brachyury Vaccine ChordomaCompletedNCT02383498Phase 2Results posted
- Photodynamic Therapy (PDT) For Recurrent High Grade GliomasTerminatedNCT01966809Phase 2Results posted
- Safety Study of Intratumoral Injection of Clostridium Novyi-NT Spores to Treat Patients With Solid Tumors That Have Not Responded to Standard TherapiesCompletedNCT01924689Phase 1Results posted
- Proton Radiation for Chordomas and ChondrosarcomasCompletedNCT01449149Not applicableResults posted
- Stereotactic Body Radiotherapy for Spine TumorsCompletedNCT01347307Not applicableResults posted
- Trial of Dasatinib in Advanced SarcomasCompletedNCT00464620Phase 2Results posted
- China Treatment Trial for Tumor in Sellar Region With Unruptured Intracranial AneurysmActive, not recruitingNCT07809178
- A Study of ERAS-601 in People With ChordomaActive, not recruitingNCT06957327Phase 1/2
- A Study of BL-B01D1 in Patients With Locally Advanced or Metastatic ChordomaActive, not recruitingNCT06787664Phase 2
- Descriptive Cohort of French Patients Treated With Carbonetherapy Since October 2010 Outside PHRC-ETOILECompletedNCT06535997
- A Prospective Study of Surgical Treatment Strategies for ChordomaStatus unknownNCT05707767Not applicable
- Tazemetostat+Nivo/Ipi in INI1-Neg/SMARCA4-Def TumorsActive, not recruitingNCT05407441Phase 1/2
- A Study to Assess the Safety and Tolerability of CFT8634 in Locally Advanced or Metastatic SMARCB1-Perturbed Cancers, Including Synovial Sarcoma and SMARCB1-Null TumorsTerminatedNCT05355753Phase 1
- Tiragolumab and Atezolizumab for the Treatment of Relapsed or Refractory SMARCB1 or SMARCA4 Deficient TumorsActive, not recruitingNCT05286801Phase 1/2
- Cetuximab for the Treatment of Advanced Unresectable or Metastatic ChordomaActive, not recruitingNCT05041127Phase 2
- A Dose Escalation/Expansion Study of ERAS-601 in Patients With Advanced or Metastatic Solid TumorsCompletedNCT04670679Phase 1
- Immunohistochemical Study of Chordomas to Improve Their Diagnosis and Prognosis CareCompletedNCT04486820
- TAEK-VAC-HerBy Vaccine for Brachyury and HER2 Expressing CancerCompletedNCT04246671Phase 1
- Long-Term Longitudinal QoL in Patients Undergoing EEAActive, not recruitingNCT04087902
- Anlotinib Hydrochloride Versus Imatinib Mesylate in Locally Advanced, Unresectable or Metastatic ChordomaStatus unknownNCT04042597Phase 2
- Pemetrexed for the Treatment of ChordomaCompletedNCT03955042Phase 1
- QUILT-3.091 NANT Chordoma Vaccine vs Radiation in Subjects With Unresectable Chordoma.WithdrawnNCT03647423Phase 1/2
- Nivolumab and Relatlimab in Treating Participants With Advanced ChordomaCompletedNCT03623854Phase 2
- CDK4/6 Inhibition in Locally Advanced/Metastatic ChordomaCompletedNCT03110744Phase 2
- Afatinib in Locally Advanced and Metastatic ChordomaCompletedNCT03083678Phase 2
- Nivolumab With or Without Stereotactic Radiosurgery in Treating Patients With Recurrent, Advanced, or Metastatic ChordomaActive, not recruitingNCT02989636Phase 1
- A Study of FAZ053 Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies.TerminatedNCT02936102Phase 1
- Nivolumab and Ipilimumab in Treating Patients With Rare TumorsActive, not recruitingNCT02834013Phase 2
- Improvement of Local Control in Skull Base, Spine and Sacral Chordomas Treated by Surgery and Protontherapy Targeting Hypoxic Cells Revealed by [18F]FAZA) PET/CT TracersCompletedNCT02802969Phase 2
- A Study of IMRT in Primary Bone and Soft Tissue SarcomaCompletedNCT02520128Not applicable
- Ion Irradiation of Sacrococcygeal ChordomaActive, not recruitingNCT01811394Phase 2
- Photodynamic Therapy (PDT) for Recurrent Pediatric Brain TumorsCompletedNCT01682746Phase 1
- Studying Genes in Tissue Samples From Younger and Adolescent Patients With Soft Tissue SarcomasCompletedNCT01567046
- Nilotinib With Radiation for High Risk ChordomaCompletedNCT01407198Phase 1
- High Dose Intensity Modulated Proton Radiation Treatment +/- Surgical Resection of Sarcomas of the Spine, Sacrum and Base of SkullActive, not recruitingNCT01346124Not applicable
- Genetic Clues to Chordoma Etiology: A Protocol to Identify Sporadic Chordoma Patients for Studies of Cancer-Susceptibility GenesActive, not recruitingNCT01200680
- Trial of Proton Versus Carbon Ion Radiation Therapy in Patients With Chordoma of the Skull BaseStatus unknownNCT01182779Phase 3
- Study of Imatinib, a Platelet-derived Growth Factor Receptor Inhibitor, and LBH589, a Histone Deacetylase Inhibitor, in the Treatment of Newly Diagnosed and Recurrent ChordomaStatus unknownNCT01175109Phase 1
- Imatinib Mesylate And Cyclophosphamide In Metronomic Administration: Dose Escalation Study Of Imatinib MesylateCompletedNCT01046487Phase 1
- Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue SarcomaCompletedNCT00919269
- Proton Therapy for Chordomas and/or ChondrosarcomasCompletedNCT00797602
- Hypoxia-positron Emission Tomography (PET) and Intensity Modulated Proton Therapy (IMPT) Dose Painting in Patients With ChordomasCompletedNCT00713037Not applicable
- Charged Particle RT for Chordomas and Chondrosarcomas of the Base of Skull or Cervical SpineCompletedNCT00592748Phase 1/2
- Proton Beam Therapy for Chordoma PatientsActive, not recruitingNCT00496119Phase 2
- Chordoma Family StudyCompletedNCT00410670
- Polyvinylpyrrolidone-Sodium Hyaluronate Gel in Reducing Pain From Oral Mucositis in Young Patients With CancerStatus unknownNCT00349024Not applicable
- Genetic Aspects of Chordoma: A Collaboration With SEER Registries to Identify Chordoma FamiliesCompletedNCT00341627
- Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare DiseasesCompletedNCT00154388Phase 2
- Efficacy and Safety of Imatinib in ChordomaCompletedNCT00150072Phase 2
- Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid TumorsTerminatedNCT00003926Phase 1